Gossamer Bio
Price & Volume
Stats
See more52W Range | $0.16-$3.87 |
Market Cap | $47.2M |
Shares Short | 40M |
Financials
See moreRevenue (12 Mos) | $55.5M |
Revenue Growth (YoY) | 71.5% |
Gross Profit (12 Mos) | $55.5M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 10 hours ago
GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
Yahoo Finance • 10 hours ago
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– HBSS
About
CEO | Mr. Faheem Hasnain |
CFO | Mr. Bryan Giraudo |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |